Sino Medical Sciences Technology In Strategic Asset Allocation Index
Sino Medical Sciences Technology In strategic asset allocation index. Sino Medical Sciences Technology In (688108) has a Strategic Asset Allocation Index of 21.4% as of June 2023. Strategic assets (PP&E of CN¥185.11 Million plus long-term investments of CN¥-) total CN¥185.11 Million, measured against net assets of CN¥864.53 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Sino Medical Sciences Technology In (688108) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Sino Medical Sciences Technology In (2016–2022)
Strategic asset allocation index of Sino Medical Sciences Technology In from 2016 to 2022. This chart shows how Sino Medical Sciences Technology In's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 21.4%, representing strategic assets of CN¥185.11 Million against net assets of CN¥864.53 Million CNY. Check 688108 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Sino Medical Sciences Technology In Strategic Asset Allocation Index by Year (2016–2022)
Sino Medical Sciences Technology In strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Sino Medical Sciences Technology In from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 688108 stock market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 19.9% | CN¥176.77 Million | CN¥176.77 Million | CN¥- | CN¥887.48 Million | ▲ +1.7 pp |
| 2021 | 18.3% | CN¥172.58 Million | CN¥172.58 Million | CN¥- | CN¥945.16 Million | ▲ +5.3 pp |
| 2020 | 12.9% | CN¥139.16 Million | CN¥139.16 Million | CN¥- | CN¥1.08 Billion | ▲ +2.3 pp |
| 2019 | 10.6% | CN¥116.38 Million | CN¥116.38 Million | CN¥- | CN¥1.10 Billion | ▲ +0.2 pp |
| 2018 | 10.4% | CN¥72.77 Million | CN¥72.77 Million | CN¥- | CN¥701.28 Million | ▲ +3.4 pp |
| 2017 | 7.0% | CN¥42.55 Million | CN¥42.55 Million | CN¥- | CN¥606.70 Million | ▼ -5.5 pp |
| 2016 | 12.5% | CN¥25.36 Million | CN¥25.36 Million | CN¥- | CN¥202.75 Million | — |